Transcript
Hi! You’re listening to the Psychopharmacology Institute podcast. I’m your host, Dr. Wegdan Rashad and this is the show that aims to help you, the mental health clinician stay sharp on psychopharm!
Today, our episode is focused on pharmacotherapy in autism spectrum disorders. Now, of course, it has to be said that medications are not the primary or the first option in the management of autism. There are behavioral and social interventions that are paramount in the management, these include applied behavior analysis (ABA) and pivotal response treatment (PRT).
But today, with Dr. Jim Phelps we will review the results of a clinical study based in South Carolina that wanted to see which was better for irritability in autism...aripiprazole or risperidone?
What
Unlock this Podcast and earn
Become a Bronze, Silver, Gold, Bronze extended, Silver extended or Gold extended Member.
Already have an account? Sign in
